<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>37(1)</volume><submitter>Najm MAA</submitter><funding>the Italian Ministry for University and Research</funding><pubmed_abstract>The present study aimed to develop potent carbonic anhydrase inhibitors (CAIs). The design of the target compounds was based on modifying the structure of the ureido-based carbonic anhydrase inhibitor SLC-0111. Six series of a substituted benzoylthioureido core were prepared featuring different zinc-binding groups; the conventional sulphamoyl group &lt;b>4a-d&lt;/b> and &lt;b>12a-c&lt;/b>, its bioisosteric carboxylic acid group &lt;b>5a-d&lt;/b> and &lt;b>13a-c&lt;/b> or the ethyl carboxylate group &lt;b>6a-d&lt;/b> and &lt;b>14a-c&lt;/b> as potential prodrugs. All compounds were assessed for their carbonic anhydrase (CA) inhibitory activity against a panel of four physiologically relevant human CA isoforms hCA I and hCA II, and hCA IX, and hCA XII. Compounds &lt;b>4a&lt;/b>, &lt;b>4b&lt;/b>, &lt;b>4c, 4d, 5d&lt;/b>, &lt;b>12a&lt;/b>, and &lt;b>12c&lt;/b</pubmed_abstract><journal>Journal of enzyme inhibition and medicinal chemistry</journal><pagination>2702-2709</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9542353</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Design and synthesis of some new benzoylthioureido phenyl derivatives targeting carbonic anhydrase enzymes.</pubmed_title><pmcid>PMC9542353</pmcid><pubmed_authors>Taher AT</pubmed_authors><pubmed_authors>Awadallah FM</pubmed_authors><pubmed_authors>Vullo D</pubmed_authors><pubmed_authors>Mahmoud WR</pubmed_authors><pubmed_authors>Najm MAA</pubmed_authors><pubmed_authors>Abbas SE</pubmed_authors><pubmed_authors>Allam HA</pubmed_authors><pubmed_authors>Supuran CT</pubmed_authors></additional><is_claimable>false</is_claimable><name>Design and synthesis of some new benzoylthioureido phenyl derivatives targeting carbonic anhydrase enzymes.</name><description>The present study aimed to develop potent carbonic anhydrase inhibitors (CAIs). The design of the target compounds was based on modifying the structure of the ureido-based carbonic anhydrase inhibitor SLC-0111. Six series of a substituted benzoylthioureido core were prepared featuring different zinc-binding groups; the conventional sulphamoyl group &lt;b>4a-d&lt;/b> and &lt;b>12a-c&lt;/b>, its bioisosteric carboxylic acid group &lt;b>5a-d&lt;/b> and &lt;b>13a-c&lt;/b> or the ethyl carboxylate group &lt;b>6a-d&lt;/b> and &lt;b>14a-c&lt;/b> as potential prodrugs. All compounds were assessed for their carbonic anhydrase (CA) inhibitory activity against a panel of four physiologically relevant human CA isoforms hCA I and hCA II, and hCA IX, and hCA XII. Compounds &lt;b>4a&lt;/b>, &lt;b>4b&lt;/b>, &lt;b>4c, 4d, 5d&lt;/b>, &lt;b>12a&lt;/b>, and &lt;b>12c&lt;/b</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-25T17:35:10.416Z</modification><creation>2025-04-06T05:03:18.212Z</creation></dates><accession>S-EPMC9542353</accession><cross_references><pubmed>36168122</pubmed><doi>10.1080/14756366.2022.2126463</doi></cross_references></HashMap>